Sign up to save your podcasts
Or
Share How Pharma Is Adopting Generative AI Across Clinical Development
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
How Pharma Is Adopting Generative AI Across Clinical Development
Summary:
In this session from DPHARM 2024, pharma experts in data science, digital innovation and development discuss the prerequisites for generative artificial intelligence (GenAI) to work well in large pharma organizations, the change management required to implement GenAI adoption, use cases and lessons learned, ensuring GenAI use is fit-for-purpose, and more.
For more information, go to DPHARMconference.com.
In this session from DPHARM 2024, pharma experts in data science, digital innovation and development discuss the prerequisites for generative artificial intelligence (GenAI) to work well in large pharma organizations, the change management required to implement GenAI adoption, use cases and lessons learned, ensuring GenAI use is fit-for-purpose, and more.
For more information, go to DPHARMconference.com.
View all episodes
By Conference ForumSummary:
In this session from DPHARM 2024, pharma experts in data science, digital innovation and development discuss the prerequisites for generative artificial intelligence (GenAI) to work well in large pharma organizations, the change management required to implement GenAI adoption, use cases and lessons learned, ensuring GenAI use is fit-for-purpose, and more.
For more information, go to DPHARMconference.com.
In this session from DPHARM 2024, pharma experts in data science, digital innovation and development discuss the prerequisites for generative artificial intelligence (GenAI) to work well in large pharma organizations, the change management required to implement GenAI adoption, use cases and lessons learned, ensuring GenAI use is fit-for-purpose, and more.
For more information, go to DPHARMconference.com.